DUBLIN, Ohio, Aug. 3, 2011 /PRNewswire/ — Cardinal Health today
announced its board of directors has approved a cash dividend of
$0.215 per share and that David P. King will join the company’s
board of directors.
At its meeting today, the board approved a quarterly dividend to
$0.215 per share, payable on Oct. 15 to shareholders of record on
Oct. 1. The dividend is the 108th consecutive regular quarterly
dividend for Cardinal Health.
The board of directors also announced the election of David P.
King as director, effective Sept. 1. King, 55, is chairman,
president and CEO of Laboratory Corp. of America Holdings
(LabCorp), an S&P 500 company and a pioneer in genomic testing
and the commercialization of new diagnostic technologies
headquartered in Burlington, NC.
“We are thrilled that Dave will be joining our board of
directors,” said George Barrett, chairman and chief executive
officer of Cardinal Health. “Dave’s knowledge of health
care and his range of experiences will add another dimension to
what is an outstanding board of directors.”
King has been with LabCorp since 2001, where he has held a
number of roles, including executive vice president and chief
operating officer; executive vice president, strategic planning and
corporate development; and senior vice president, general counsel
and chief compliance officer. During his tenure, he has expanded
the company’s scientific leadership with the introduction of new
genetic tests and the acquisitions of Monogram Biosciences and
Genzyme Genetics. He has also built its international presence in
Asia, Europe and the Middle East.
King has more than 25 years of experience in both the public and
the private sector. Prior to joining LabCorp, he served in the
Department of Justice as an Assistant United States Attorney and as
a partner in a private law firm.
King is the chairman of the American Clinical Laboratory
Association. He also serves o